Opendata, web and dolomites

MITrep

Automated mini-invasive surgical approach to the treatment of mitral insufficiency

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 MITrep project word cloud

Explore the words cloud of the MITrep project. It provides you a very rough idea of what is the project "MITrep" about.

reduce    followed    300    trial    75    leak    patient    sudden    error    risk    age    specialist    80k    ring    patented    gold    feasibility    half    post    context    shortness    transapical    surgical    returns    affix    times    deployment    invasive    double    moderate    inoperable    annuloplasty    aortic    mini    automatically    hospitalization    vs    30k    first    heart    80    anchored    mitral    tested    tricuspid    dramatic    10    preventing    prevalence    mainly    surgeries    breath    goes    safety    improvement    cmi    days    leaking    unbearable    normal    care    elderly    mitrep    healthcare    surgery    insufficiency    worldwide    symptoms    starting    transfemoral    operation    afflicts    time    device    surgeons    aged    validate    racing    chronic    operations    efficiency    severe    replicable    skilled    standard    rate    patients    hours    death    blood    halve    palpitations    nov    abnormally    ambition    stroke    icu    lack    tagged    usa    intensive    driver    fatigue    repair    valve    uses    once    holds    valvuloplasty    fragile    company    2030    hospital    heavy   

Project "MITrep" data sheet

The following table provides information about the project.

Coordinator
CMI NOV 

Organization address
address: BATIMENT 4 PUISSANCE 3 ZA CHAVANON
city: MONISTROL SUR LOIRE
postcode: 43120
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Project website http://www.cmi-nov.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-12-01   to  2019-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CMI NOV FR (MONISTROL SUR LOIRE) coordinator 50˙000.00

Map

 Project objective

Mitral valve insufficiency is a heart condition, where blood is abnormally leaking out of the mitral valve. This condition mainly afflicts the elderly patients: - 80% of patients aged 80 show moderate symptoms (chronic fatigue, shortness of breath, palpitations, racing heart rate) - 10% of patients above 75 with severe symptoms are at risk of a sudden death (stroke) within 5 years. - Prevalence will double by 2030. Mitral insufficiency is treated with open heart surgery (300,000 operations/year in the EU and the USA) followed by intensive care. But this operation is unbearable for fragile patients. Half of the patients above 75 are tagged inoperable because of their age. Less invasive repair surgeries have been tested (annuloplasty by transfemoral surgery) but lack efficiency and safety and require highly skilled surgeons (not available in each hospital). In this context, the company CMI’nov has developed MITrep, the first patented mini-invasive surgical device that automatically goes to the mitral valve with no trial and error to affix a leak-preventing ring on the valve. It uses the transapical approach. Once the ring is anchored, the mitral valve returns to normal activity. No heavy post-surgery effects are expected. No intensive care required.

MITrep can be used by any surgeons : no need to be a mitral valve specialist. It will allow to halve the operation time (from 5 hours to less than 2 hours), reduce hospitalization time to 3 days (vs 5-8 days with 2 days in ICU) and cost about three times less than open heart surgery (30k€ vs 80k€). It means a dramatic cost reduction for healthcare systems and a real improvement of the care of the elderly patient.

This project holds the ambition to build a new gold standard in valvuloplasty worldwide, starting with mitral repair and replicable to aortic and tricuspid valve repair. It is also a value driver for CMI’nov. The Phase 1 project will validate the feasibility of MITrep before scale-up and deployment.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MITREP" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MITREP" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

DNA DS (2019)

DNA Data storage

Read More  

ERGOVIAkinematix (2018)

New wearable measurement devices for Industry 4.0 based on gaming motion-capture system

Read More  

Magnesys (2019)

Efficient filtering of metallic impurities in food processing

Read More